132 related articles for article (PubMed ID: 12148718)
1. Relative biological effectiveness enhancement of a 125I brachytherapy seed with characteristic x rays from its constitutive materials.
Taschereau R; Roy R; Pouliot J
Med Phys; 2002 Jul; 29(7):1397-402. PubMed ID: 12148718
[TBL] [Abstract][Full Text] [Related]
2. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
Wuu CS; Chen J
Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
4. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
Wang JZ; Mayr NA; Nag S; Montebello J; Gupta N; Samsami N; Kanellitsas C
Med Phys; 2006 Apr; 33(4):1025-32. PubMed ID: 16696479
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
6. A calculation of the relative biological effectiveness of 125I and 103Pd brachytherapy sources using the concept of proximity function.
Wuu CS; Zaider M
Med Phys; 1998 Nov; 25(11):2186-9. PubMed ID: 9829243
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Chibani O; Williamson JF; Todor D
Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
[TBL] [Abstract][Full Text] [Related]
8. Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
Yue N; Chen Z; Nath R
Phys Med Biol; 2002 Apr; 47(7):1185-204. PubMed ID: 11996063
[TBL] [Abstract][Full Text] [Related]
9. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
10. A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd.
Antipas V; Dale RG; Coles IP
Phys Med Biol; 2001 Oct; 46(10):2557-69. PubMed ID: 11686275
[TBL] [Abstract][Full Text] [Related]
11. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
Lindsay P; Battista J; Van Dyk J
Med Phys; 2001 Mar; 28(3):336-45. PubMed ID: 11318315
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric characteristics of the DRAXIMAGE model LS-1 1-125 interstitial brachytherapy source design: a Monte Carlo investigation.
Williamson JF
Med Phys; 2002 Apr; 29(4):509-21. PubMed ID: 11991122
[TBL] [Abstract][Full Text] [Related]
13. Determination of the prescription dose for biradionuclide permanent prostate brachytherapy.
Nuttens VE; Lucas S
Med Phys; 2008 Dec; 35(12):5451-62. PubMed ID: 19175105
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
Thomson RM; Taylor RE; Rogers DW
Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
[TBL] [Abstract][Full Text] [Related]
15. A Monte Carlo study on the effect of seed design on the interseed attenuation in permanent prostate implants.
Afsharpour H; D'Amours M; Coté B; Carrier JF; Verhaegen F; Beaulieu L
Med Phys; 2008 Aug; 35(8):3671-81. PubMed ID: 18777927
[TBL] [Abstract][Full Text] [Related]
16. More accurate fitting of 125I and 103Pd radial dose functions.
Taylor RE; Rogers DW
Med Phys; 2008 Sep; 35(9):4242-50. PubMed ID: 18841874
[TBL] [Abstract][Full Text] [Related]
17. Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sources.
Wuu CS; Kliauga P; Zaider M; Amols HI
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):689-97. PubMed ID: 8948355
[TBL] [Abstract][Full Text] [Related]
18. Impact of interseed attenuation and tissue composition for permanent prostate implants.
Carrier JF; Beaulieu L; Therriault-Proulx F; Roy R
Med Phys; 2006 Mar; 33(3):595-604. PubMed ID: 16878563
[TBL] [Abstract][Full Text] [Related]
19. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
Dicker AP; Lin CC; Leeper DB; Waterman FM
Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
[TBL] [Abstract][Full Text] [Related]
20. Experimental determination of the anisotropy function for the model 200 103Pd "light seed" and derivation of the anisotropy constant based upon the linear quadratic model.
Yue N; Nath R
Med Phys; 2002 Jun; 29(6):1120-9. PubMed ID: 12094982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
